1. Cell Biology
  2. Microbiology and Infectious Disease

Class-A penicillin binding proteins do not contribute to cell shape but repair cell-wall defects

  1. Antoine Vigouroux
  2. Baptiste Cordier
  3. Andrey Aristov
  4. Laura Alvarez
  5. Gizem Özbaykal
  6. Thibault Chaze
  7. Enno Rainer Oldewurtel
  8. Mariette Matondo
  9. Felipe Cava
  10. David Bikard
  11. Sven van Teeffelen  Is a corresponding author
  1. Institut Pasteur, France
  2. Umeå University, Sweden
https://doi.org/10.7554/eLife.51998
Share this article
Cite this article
  1. Antoine Vigouroux
  2. Baptiste Cordier
  3. Andrey Aristov
  4. Laura Alvarez
  5. Gizem Özbaykal
  6. Thibault Chaze
  7. Enno Rainer Oldewurtel
  8. Mariette Matondo
  9. Felipe Cava
  10. David Bikard
  11. Sven van Teeffelen
(2020)
Class-A penicillin binding proteins do not contribute to cell shape but repair cell-wall defects
eLife 9:e51998.
https://doi.org/10.7554/eLife.51998
  2. Download BibTeX
  3. Download .RIS

Abstract

Cell shape and cell-envelope integrity of bacteria are determined by the peptidoglycan cell wall. In rod-shaped Escherichia coli, two conserved sets of machinery are essential for cell-wall insertion in the cylindrical part of the cell: the Rod complex and the class-A penicillin-binding proteins (aPBPs). While the Rod complex governs rod-like cell shape, aPBP function is less well understood. aPBPs were previously hypothesized to either work in concert with the Rod complex or to independently repair cell-wall defects. First, we demonstrate through modulation of enzyme levels that aPBPs do not contribute to rod-like cell shape but are required for mechanical stability, supporting their independent activity. By combining measurements of cell-wall stiffness, cell-wall insertion, and PBP1b motion at the single-molecule level we then present evidence that PBP1b, the major aPBP, contributes to cell-wall integrity by repairing cell wall defects.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files or deposited on Dryad. Source data files have been provided for Figures 1-4.Dryad datasets:Tracking data Tracking.zip: https://doi.org/10.5061/dryad.m37pvmcxq.SDS-Page raw images: https://doi.org/10.5061/dryad.9s4mw6mb9

The following data sets were generated

Article and author information

Author details

  1. Antoine Vigouroux

    Microbial Morphogenesis and Growth Laboratory, Institut Pasteur, Paris, France
    Competing interests
    The authors declare that no competing interests exist.

  2. Baptiste Cordier

    Microbial Morphogenesis and Growth Laboratory, Institut Pasteur, Paris, France
    Competing interests
    The authors declare that no competing interests exist.

  3. Andrey Aristov

    Microbial Morphogenesis and Growth Laboratory, Institut Pasteur, Paris, France
    Competing interests
    The authors declare that no competing interests exist.

  4. Laura Alvarez

    Laboratory for Molecular Infection Medicine Sweden (MIMS), Umeå University, Umeå, Sweden
    Competing interests
    The authors declare that no competing interests exist.

  5. Gizem Özbaykal

    Microbial Morphogenesis and Growth Laboratory, Institut Pasteur, Paris, France
    Competing interests
    The authors declare that no competing interests exist.

  6. Thibault Chaze

    Proteomics Platform, Institut Pasteur, Paris, France
    Competing interests
    The authors declare that no competing interests exist.

  7. Enno Rainer Oldewurtel

    Microbial Morphogenesis and Growth Laboratory, Institut Pasteur, Paris, France
    Competing interests
    The authors declare that no competing interests exist.

  8. Mariette Matondo

    Proteomics Platform, Institut Pasteur, Paris, France
    Competing interests
    The authors declare that no competing interests exist.

  9. Felipe Cava

    Laboratory for Molecular Infection Medicine Sweden (MIMS), Umeå University, Umeå, Sweden
    Competing interests
    The authors declare that no competing interests exist.

  10. David Bikard

    Synthetic Biology Laboratory, Institut Pasteur, Paris, France
    Competing interests
    The authors declare that no competing interests exist.

  11. Sven van Teeffelen

    Microbial Morphogenesis and Growth Laboratory, Institut Pasteur, Paris, France
    For correspondence
    sven.vanteeffelen@gmail.com
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0877-1294

Funding

H2020 European Research Council (679980)

  • Sven van Teeffelen

Agence Nationale de la Recherche (ANR-10-LABX-62-IBEID)

  • Antoine Vigouroux
  • David Bikard
  • Sven van Teeffelen

Volkswagen Foundation

  • Sven van Teeffelen

Mairie de Paris (Emergence(s))

  • Sven van Teeffelen

H2020 European Research Council (677823)

  • David Bikard

Knut och Alice Wallenbergs Stiftelse

  • Felipe Cava

Swedish Research Council

  • Felipe Cava

Kempe Foundation

  • Felipe Cava

Laboratory for Molecular Infection Medicine Sweden

  • Felipe Cava

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2020, Vigouroux et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 5,259
    views
  • 718
    downloads
  • 116
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Antoine Vigouroux
  2. Baptiste Cordier
  3. Andrey Aristov
  4. Laura Alvarez
  5. Gizem Özbaykal
  6. Thibault Chaze
  7. Enno Rainer Oldewurtel
  8. Mariette Matondo
  9. Felipe Cava
  10. David Bikard
  11. Sven van Teeffelen
(2020)
Class-A penicillin binding proteins do not contribute to cell shape but repair cell-wall defects
eLife 9:e51998.
https://doi.org/10.7554/eLife.51998

Share this article

https://doi.org/10.7554/eLife.51998

Categories and tags

Research organism

Further reading

    1. Cell Biology

    Small-molecule activation of TFEB alleviates Niemann–Pick disease type C via promoting lysosomal exocytosis and biogenesis

    Kaili Du, Hongyu Chen ... Dan Li
    Research Article

    Niemann–Pick disease type C (NPC) is a devastating lysosomal storage disease characterized by abnormal cholesterol accumulation in lysosomes. Currently, there is no treatment for NPC. Transcription factor EB (TFEB), a member of the microphthalmia transcription factors (MiTF), has emerged as a master regulator of lysosomal function and promoted the clearance of substrates stored in cells. However, it is not known whether TFEB plays a role in cholesterol clearance in NPC disease. Here, we show that transgenic overexpression of TFEB, but not TFE3 (another member of MiTF family) facilitates cholesterol clearance in various NPC1 cell models. Pharmacological activation of TFEB by sulforaphane (SFN), a previously identified natural small-molecule TFEB agonist by us, can dramatically ameliorate cholesterol accumulation in human and mouse NPC1 cell models. In NPC1 cells, SFN induces TFEB nuclear translocation via a ROS-Ca2+-calcineurin-dependent but MTOR-independent pathway and upregulates the expression of TFEB-downstream genes, promoting lysosomal exocytosis and biogenesis. While genetic inhibition of TFEB abolishes the cholesterol clearance and exocytosis effect by SFN. In the NPC1 mouse model, SFN dephosphorylates/activates TFEB in the brain and exhibits potent efficacy of rescuing the loss of Purkinje cells and body weight. Hence, pharmacological upregulating lysosome machinery via targeting TFEB represents a promising approach to treat NPC and related lysosomal storage diseases, and provides the possibility of TFEB agonists, that is, SFN as potential NPC therapeutic candidates.

    1. Cell Biology

    Stratification of enterochromaffin cells by single-cell expression analysis

    Yan Song, Linda J Fothergill ... Gene W Yeo
    Research Article

    Dynamic interactions between gut mucosal cells and the external environment are essential to maintain gut homeostasis. Enterochromaffin (EC) cells transduce both chemical and mechanical signals and produce 5-hydroxytryptamine to mediate disparate physiological responses. However, the molecular and cellular basis for functional diversity of ECs remains to be adequately defined. Here, we integrated single-cell transcriptomics with spatial image analysis to identify 14 EC clusters that are topographically organized along the gut. Subtypes predicted to be sensitive to the chemical environment and mechanical forces were identified that express distinct transcription factors and hormones. A Piezo2+ population in the distal colon was endowed with a distinctive neuronal signature. Using a combination of genetic, chemogenetic, and pharmacological approaches, we demonstrated Piezo2+ ECs are required for normal colon motility. Our study constructs a molecular map for ECs and offers a framework for deconvoluting EC cells with pleiotropic functions.

    1. Cell Biology
    2. Developmental Biology

    Lens Development: Bringing signaling complexity into focus

    Sarah Y Coomson, Salil A Lachke
    Insight

    A study in mice reveals key interactions between proteins involved in fibroblast growth factor signaling and how they contribute to distinct stages of eye lens development.